| Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene … P Argani, C Iacobuzio-Donahue, B Ryu, C Rosty, M Goggins, RE Wilentz, ... Clinical cancer research 7 (12), 3862-3868, 2001 | 712 | 2001 |
| Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays CA Iacobuzio-Donahue, A Maitra, M Olsen, AW Lowe, NT Van Heek, ... The American journal of pathology 162 (4), 1151-1162, 2003 | 573 | 2003 |
| Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology C Rosty, L Christa, S Kuzdzal, WM Baldwin, ML Zahurak, F Carnot, ... Cancer research 62 (6), 1868-1875, 2002 | 507 | 2002 |
| Association between molecular subtypes of colorectal cancer and patient survival AI Phipps, PJ Limburg, JA Baron, AN Burnett-Hartman, DJ Weisenberger, ... Gastroenterology 148 (1), 77-87. e2, 2015 | 452 | 2015 |
| Prevalence and penetrance of major genes and polygenes for colorectal cancer AK Win, MA Jenkins, JG Dowty, AC Antoniou, A Lee, GG Giles, ... Cancer Epidemiology, Biomarkers & Prevention 26 (3), 404-412, 2017 | 435 | 2017 |
| Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma P Argani, C Rosty, RE Reiter, RE Wilentz, SR Murugesan, SD Leach, ... Cancer research 61 (11), 4320-4324, 2001 | 405 | 2001 |
| The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma M Tascilar, HG Skinner, C Rosty, T Sohn, RE Wilentz, GJA Offerhaus, ... Clinical Cancer Research 7 (12), 4115-4121, 2001 | 399 | 2001 |
| Frequent hypomethylation of multiple genes overexpressed in pancreatic ductal adenocarcinoma N Sato, A Maitra, N Fukushima, NT Van Heek, H Matsubayashi, ... Cancer research 63 (14), 4158-4166, 2003 | 378 | 2003 |
| APC and oncogenic KRAS are synergistic in enhancing Wnt signaling in intestinal tumor formation and progression KP Janssen, P Alberici, H Fsihi, C Gaspar, C Breukel, P Franken, C Rosty, ... Gastroenterology 131 (4), 1096-1109, 2006 | 339 | 2006 |
| Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation C Rosty, T Ueki, P Argani, M Jansen, CJ Yeo, JL Cameron, RH Hruban, ... The American journal of pathology 160 (1), 45-50, 2002 | 314 | 2002 |
| STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas N Sato, C Rosty, M Jansen, N Fukushima, T Ueki, CJ Yeo, JL Cameron, ... The American journal of pathology 159 (6), 2017-2022, 2001 | 306 | 2001 |
| Wide metastatic spreading in infiltrating lobular carcinoma of the breast S Ferlicot, A Vincent-Salomon, J Medioni, P Genin, C Rosty, ... European Journal of Cancer 40 (3), 336-341, 2004 | 273 | 2004 |
| Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma N Fukushima, N Sato, T Ueki, C Rosty, KM Walter, RE Wilentz, CJ Yeo, ... The American journal of pathology 160 (5), 1573-1581, 2002 | 265 | 2002 |
| Risks of primary extracolonic cancers following colorectal cancer in lynch syndrome AK Win, NM Lindor, JP Young, FA Macrae, GP Young, E Williamson, ... Journal of the National Cancer Institute 104 (18), 1363-1372, 2012 | 257 | 2012 |
| Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses MC Etienne, M Chazal, P Laurent-Puig, N Magné, C Rosty, JL Formento, ... Journal of clinical oncology 20 (12), 2832-2843, 2002 | 227 | 2002 |
| Prediction of overall survival in stage II and III colon cancer beyond TNM system: a retrospective, pooled biomarker study R Dienstmann, MJ Mason, FA Sinicrope, AI Phipps, S Tejpar, ... Annals of Oncology 28 (5), 1023-1031, 2017 | 226 | 2017 |
| Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype MD Walsh, M Clendenning, E Williamson, SA Pearson, RJ Walters, ... Modern Pathology 26 (12), 1642-1656, 2013 | 222 | 2013 |
| Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer AK Win, JG Dowty, SP Cleary, H Kim, DD Buchanan, JP Young, ... Gastroenterology 146 (5), 1208-1211. e5, 2014 | 221 | 2014 |
| Early detection of pancreatic carcinoma C Rosty, M Goggins Hematology/Oncology Clinics 16 (1), 37-52, 2002 | 214 | 2002 |
| Clinicopathological and molecular features of sessile serrated adenomas with dysplasia or carcinoma M Bettington, N Walker, C Rosty, I Brown, A Clouston, D McKeone, ... Gut 66 (1), 97-106, 2017 | 210 | 2017 |
